In this prospective cohort study of stroke patients, we found that the presence of CHIP was associated with the risk of short-term unfavorable functional outcomes in patients with LAA under hyper-inflammation, and that a genetic IL-6 signaling deficiency could attenuate the risk of unfavorable functional outcomes in patients with LAA stroke and CHIP. This evidence concerns the gene IL6 and stroke disorder.